Abstract
Glycosides are a group of naturally occurring compounds found in a variety of plant families, explored for their antibacterial, antifungal, anti-inflammatory, antioxidant, antiviral and anticancer activities. There are more than 11 distinguished classes including anthraquinone, cardiac, chromone, coumarin, cyanogenic, flavonoid, saponin, steroidal and steviol glycosides. Due to the extensive variability in their structures, some glycosides have always displayed antitumour and cytotoxic properties through a variety of pathways. A large number of glycosides still remain to be explored for their antitumour potential. Taking into consideration the pace with which new entities are being discovered and investigated, it is essential to gather all the latest information, on the previously investigated molecules, under one roof which might help young researchers in understanding the current status of glycosides in cancer therapy research. The aim of this review is to collate many such structures and their related chemistry along with the understanding of their mechanism of action and structure activity relationships. The review focuses mainly on anthraquinone, coumarin and flavonoid glycosides and contribution of substituents on their glycone and aglycone moiety towards the antitumour property. Compounds such as Didymin, Digitoxin, Dioscin, Esculetin, Genistein, OSW-1, Tubeimoside and many more have been discussed here.
Keywords: Antitumour, Cell lines, Cytotoxic, Glycosides, Mechanism of action, Structure-activity relationship.
Current Bioactive Compounds
Title:Plant Glycosides and Aglycones Displaying Antiproliferative and Antitumour Activities – A Review
Volume: 9 Issue: 4
Author(s): Aenakshi Shah, Chitra Varma, Sandeep Patankar and Vilasrao Kadam
Affiliation:
Keywords: Antitumour, Cell lines, Cytotoxic, Glycosides, Mechanism of action, Structure-activity relationship.
Abstract: Glycosides are a group of naturally occurring compounds found in a variety of plant families, explored for their antibacterial, antifungal, anti-inflammatory, antioxidant, antiviral and anticancer activities. There are more than 11 distinguished classes including anthraquinone, cardiac, chromone, coumarin, cyanogenic, flavonoid, saponin, steroidal and steviol glycosides. Due to the extensive variability in their structures, some glycosides have always displayed antitumour and cytotoxic properties through a variety of pathways. A large number of glycosides still remain to be explored for their antitumour potential. Taking into consideration the pace with which new entities are being discovered and investigated, it is essential to gather all the latest information, on the previously investigated molecules, under one roof which might help young researchers in understanding the current status of glycosides in cancer therapy research. The aim of this review is to collate many such structures and their related chemistry along with the understanding of their mechanism of action and structure activity relationships. The review focuses mainly on anthraquinone, coumarin and flavonoid glycosides and contribution of substituents on their glycone and aglycone moiety towards the antitumour property. Compounds such as Didymin, Digitoxin, Dioscin, Esculetin, Genistein, OSW-1, Tubeimoside and many more have been discussed here.
Export Options
About this article
Cite this article as:
Shah Aenakshi, Varma Chitra, Patankar Sandeep and Kadam Vilasrao, Plant Glycosides and Aglycones Displaying Antiproliferative and Antitumour Activities – A Review, Current Bioactive Compounds 2013; 9 (4) . https://dx.doi.org/10.2174/1573407209999131231095332
DOI https://dx.doi.org/10.2174/1573407209999131231095332 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment
Current Vascular Pharmacology Evaluation of Non-Coding RNAs as Potential Targets in Head and Neck Squamous Cell Carcinoma Cancer Stem Cells
Current Drug Targets miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents
Current Cancer Drug Targets The Role of Bax/Bcl-2 and Pro-Caspase Peptides in Hypoxia/Reperfusion-Dependent Regulation of MAPKERK: Discordant Proteomic Effect of MAPKp38
Protein & Peptide Letters In Utero Gene Therapy: Prospect and Future
Current Pharmaceutical Design Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Current Pharmaceutical Design Mechanisms of Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-Small-Cell Lung Cancer: Clinical and Molecular Considerations
Current Medicinal Chemistry Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions
Current Genomics Cytotoxicity of Novel Sulfanilamides Towards Sensitive and Multidrugresistant Leukemia Cells
Current Medicinal Chemistry Small Molecule Inhibition of the Bcl-XL-BH3 Protein-Protein Interaction: Proof-of-Concept of an In Vivo Chemopotentiator ABT-737
Current Topics in Medicinal Chemistry Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas
Current Stem Cell Research & Therapy Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy
Current Medicinal Chemistry IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets Three Amino Acid Derivatives of Valproic Acid: Design, Synthesis, Theoretical and Experimental Evaluation as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry The use of nanocarriers in acute myeloid leukaemia therapy: challenges and current status.
Current Pharmaceutical Biotechnology Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry Isolation, Purification, Characterisation and Application of L-ASNase: A Review
Recent Patents on Biotechnology Radiolabeled Oligonucleotides for Antisense Imaging
Current Organic Synthesis Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry